H.Res. 1285 expresses the opinion of the House of Representatives that extensive evidence and numerous peer-reviewed studies demonstrate that mifepristone, a medication used for medical abortions, is both safe and effective. The resolution calls for respect for this body of evidence in discussions about laws and policies related to access to mifepristone.
Media coverage has highlighted the resolution as a reaffirmation of scientific evidence supporting mifepristone's safety and effectiveness. Supporters argue that the resolution underscores the importance of basing health policy on rigorous scientific research, which they believe is crucial for women's health rights.
Critics in the media have pointed out that the resolution may be seen as a partisan effort to protect abortion access amid ongoing debates about reproductive rights. Some have expressed concerns that it disregards the perspectives of those who oppose abortion and could further polarize discussions on the issue.
The analysis of H.Res. 1285, which addresses the safety and effectiveness of mifepristone, reveals no direct industry overlaps between the sponsor, Diana DeGette's top donor industries and the bill's subject matter. While there is lobbying activity in the healthcare sector, including contributions from the American Academy of Pediatrics ($10,000) and BAMCO LLC ($110,000), these do not directly correlate with mifepristone or abortion-related policies. The absence of significant financial ties to the pharmaceutical industry or reproductive health organizations suggests a low risk of conflict of interest. Voters should note that while lobbying is present, the lack of direct donor influence on the bill's topic indicates that the sponsor is likely acting in the public interest rather than under donor pressure.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| BAMCO LLC | CHECKMATE GOVERNMENT RELATIONS | $110,000 |
| TRANSPORTATION COMMUNICATIONS NATIONAL UNION/IAM (FKA TRANSPORTATION COMMUNICATI | TRANSPORTATION COMMUNICATIONS NATIONAL UNION/IAM (FKA TRANSPORTATION COMMUNICATI | $70,000 |
| MCCORMICK & COMPANY, INCORPORATED | MCCORMICK & COMPANY, INCORPORATED | $20,000 |
| AMERICAN ACADEMY OF PEDIATRICS | HARO SOLUTIONS LLC | $10,000 |
| INTERCOMP COMPANY | BROMELKAMP GOVERNMENT RELATIONS, LLC | $10,000 |
| CONSUMER BANKERS ASSOCIATION | 1607 STRATEGIES, LLC | $10,000 |
| NATIONAL ASSOCIATION FOR GIFTED CHILDREN | JENNIFER MADSEN | undisclosed |
| AMERICAN COMMERCIAL BARGE LINE LLC | AMERICAN COMMERCIAL BARGE LINES, LLC | undisclosed |
| GALVANIZE THERAPEUTICS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | undisclosed |
| NEURALINK CORP. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | undisclosed |
| CAPITOL COUNSEL LLC ON BEHALF OF SKYVAULT AI LLC | MICHAEL J. LAMOUREUX | undisclosed |
| PRECISION IMPACTS, LLC | THORN RUN PARTNERS | undisclosed |
| CITY OF FREDERICK OKLAHOMA | BROMELKAMP GOVERNMENT RELATIONS, LLC | undisclosed |
| TWINLOGIC STRATEGIES ON BEHALF OF PEW CHARITABLE TRUSTS | WINN STRATEGIES, LLC | undisclosed |
| MONUMENT HILLS PARTNERS, LLC | THE BERNHARDT GROUP LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Diana DeGette, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
